Ms Emma Doherty > Matheson LLP > Dublin, Ireland > Lawyer Profile

Matheson LLP
70 SIR JOHN ROGERSON'S QUAY
DUBLIN 2
Ireland
Emma Doherty photo

Work Department

Partner in US Business and Inward Investment Groups

Position

Emma Doherty is a partner and a member of the US Business and Inward Investment Groups at Matheson.

Emma practises corporate law and regularly spends time in the US with her clients.  She works with international companies on the establishment, expansion and operation of their businesses in Ireland.  Emma also advises clients on the complex legal issues that can arise on international transactions involving Irish subsidiaries of foreign companies, including advising on a broad range of corporate reorganisations.  Emma regularly leads group-wide multi-jurisdictional international restructuring projects.

Emma also advises corporate clients on a broad range of contract, corporate governance and business-related issues, including directors’ duties and compliance matters.  In addition, she provides ongoing corporate advice and strategic counselling to clients, including advice in relation to distributions and complex cash repatriation strategies.

Emma is a member of the Company Law Review Group, the statutory advisory expert body charged with advising the Minister for Business, Enterprise & Innovation on the review and development of company law in Ireland.

Education

University College Dublin, Bachelor of Business and Law (BBLS)
Solicitor, Law Society of Ireland
Chartered Tax Advisor, Irish Taxation Institute
Qualified as a solicitor in England and Wales (non-practising)
Associate Member, American Bar Association (ABA)

Lawyer Rankings

Ireland > Healthcare and life sciences

Matheson LLP is a major force in life sciences transactions, including M&A and restructurings, along with healthcare litigation and regulatory matters. It has advised clients on some of the largest life sciences deals of recent years, such as representing Horizon Therapeutics in the proposed $28bn acquisition by Pillartree (a wholly owned subsidiary of Amgen), implemented as an Irish High Court-sanctioned scheme of arrangement. It has defended clients in a series of cases linked to the CervicalCheck scandal, along with other headline healthcare cases. Rebecca Ryan is head of healthcare, specialising in medical negligence and clinical malpractice. Kate McKenna is noted for life sciences regulatory matters and David Fitzgibbon is a leader in life sciences M&A. Emma Doherty is key for corporate governance in both life sciences and healthcare. John Coary was recently promoted to partner.